Nephrolithiasis and renal calcifications in primary hyperparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 8, 2011, Pages 2377-2385

  Rejnmark, Lars ^a   Vestergaard, Peter ^a   Mosekilde, Leif ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CITRATE POTASSIUM; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATE; THIAZIDE DIURETIC AGENT;

AGE; CALCIUM EXCRETION; CALCIUM URINE LEVEL; GENDER; HOSPITAL ADMISSION; HUMAN; HYPERCALCIURIA; IDIOPATHIC DISEASE; KIDNEY CALCIFICATION; NEPHROLITHIASIS; PAIN; PARATHYROIDECTOMY; PATHOPHYSIOLOGY; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT INDICATION;

CALCINOSIS; HUMANS; HYPERPARATHYROIDISM, PRIMARY; KIDNEY; NEPHROLITHIASIS; RISK FACTORS;

EID: 79961240756     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0569     Document Type: Review

References (69)

1. Park S, Pearle MS 2007 Pathophysiology and management of calcium stones. Urol Clin North Am 34:323-334 (Pubitemid 47189601)
2. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC 2003 Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63:1817-1823 (Pubitemid 36513328)
3. Eskelinen M, Ikonen J, Lipponen P 1998 Usefulness of history-taking, physical examination and diagnostic scoring in acute renal colic. Eur Urol 34:467-473 (Pubitemid 28550309)
4. Pak CY 1991 Etiology and treatment of urolithiasis. Am J Kidney Dis 18:624-637
5. Heath 3rd H 1991 Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology. J Bone Miner Res 6:S63-S70; discussion S83-S84
6. Pak CY, Nicar MJ, Peterson R, Zerwekh JE, Snyder W 1981 A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism. J Clin Endocrinol Metab 53:536-542 (Pubitemid 12005795)
7. Broadus AE, Horst RL, Lang R, Littledike ET, Rasmussen H 1980 The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. N Engl J Med 302:421-426 (Pubitemid 10169245)
8. Miller NL, Humphreys MR, Coe FL, Evan AP, Bledsoe SB, Handa SE, Lingeman JE 2010 Nephrocalcinosis: re-defined in the era of endourology. Urol Res 38:421-427
9. Suh JM, Cronan JJ, Monchik JM 2008 Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? AJR Am J Roentgenol 191:908-911
10. Moosgaard B, Vestergaard P, Heickendorff L, Mosekilde L 2007 Plasma 1,25-dihydroxyvitamin-D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function. Clin Endocrinol (Oxf) 66:35-42 (Pubitemid 44952492)
11. Tassone F, Gianotti L, Emmolo I, Ghio M, Borretta G 2009 Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 94:4458-4461
12. Khaleeli AA, Johnson JN, Taylor WH 2007 Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy. Diabetes Metab Res Rev 23:43-48 (Pubitemid 46152485)
13. Pak CY 1979 Effect of parathyroidectomy on crystallization of calcium salts in urine of patients with primary hyperparathyroidism. Invest Urol 17:146-148 (Pubitemid 10132541)
14. Parks JH, Coe FL, Evan AP, Worcester EM 2009 Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int 103:670-678
15. Söreide JA, van Heerden JA, Grant CS, Lo CY, Ilstrup DM 1996 Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal stones. Surgery 120:1033-1037; discussion 1037-1038
16. Corbetta S, Baccarelli A, Aroldi A, Vicentini L, Fogazzi GB, Eller-Vainicher C, Ponticelli C, Beck-Peccoz P, Spada A 2005 Risk factors associated to kidney stones in primary hyperparathyroidism. J Endocrinol Invest 28:122-128 (Pubitemid 43162787)
17. Silverberg SJ, Shane E, Jacobs TP, Siris ES, Gartenberg F, Seldin D, Clemens TL, Bilezikian JP 1990 Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 89:327-334 (Pubitemid 20323260)
18. Frøkjaer VG, Mollerup CL 2002 Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone disease before and after parathyroidectomy. World J Surg 26:532-535 (Pubitemid 36920360)
19. Odvina CV, Sakhaee K, Heller HJ, Peterson RD, Poindexter JR, Padalino PK, Pak CY 2007 Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol Res 35:123-128 (Pubitemid 46828954)
20. Patron P, Gardin JP, Paillard M 1987 Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism. Kidney Int 31:1174-1180 (Pubitemid 17069102)
21. Thakker RV, Fraher LJ, Adami S, Karmali R, O'Riordan JL 1986 Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism. Bone Miner 1:137-144 (Pubitemid 16018089)
22. D'Angelo A, Lodetti MG, Giannini S, Castrignano R, al Awady M, Malvasi L, Fabris A, Maschio G 1992 Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis? Miner Electrolyte Metab 18:359-364 (Pubitemid 23016167)
23. Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L 2005 Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 63:506-513 (Pubitemid 41626744)
24. Ba J, Brown D, Friedman PA 2003 Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am J Physiol Renal Physiol 285:F1233-F1243 (Pubitemid 37421059)
25. Renkema KY, Velic A, Dijkman HB, Verkaart S, van der Kemp AW, Nowik M, Timmermans K, Doucet A, Wagner CA, Bindels RJ, Hoenderop JG 2009 The calcium-sensing receptor promotes urinary acidification to prevent nephrolithiasis. J Am Soc Nephrol 20:1705-1713
26. Sands JM, Naruse M, Baum M, Jo I, Hebert SC, Brown EM, Harris HW 1997 Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 99:1399-1405 (Pubitemid 27142778)
27. Scillitani A, Guarnieri V, Battista C, DeGeronimo S, Muscarella LA, Chiodini I, Cignarelli M, Minisola S, Bertoldo F, Francucci CM, Malavolta N, Piovesan A, Mascia ML, Muscarella S, Hendy GN, D'Agruma L, Cole DE 2007 Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. J Clin Endocrinol Metab 92:277-283 (Pubitemid 46067544)
28. Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G, Brandi ML 2002 Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 13:2517-2523
29. Vezzoli G, Terranegra A, Arcidiacono T, Gambaro G, Milanesi L, Mosca E, Soldati L, on behalf of GENIAL network (Genetics and Environment in Nephrolithiasis Italian Alliance) 2010 Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region. Nephrol Dial Transplant 25:2245-2252
30. Paillard M, Gardin JP, Borensztein P, Prigent A 1989 Determinants of parathormone secretion in primary hyperparathyroidism. Horm Res 32:89-92 (Pubitemid 20032083)
31. Cooperberg MR, Duh QY, Stackhouse GB, Stoller ML 2007 Oral calcium supplementation associated with decreased likelihood of nephrolithiasis prior to surgery for hyperparathyroidism. Int J Urol 14:1113-1115 (Pubitemid 350151267)
32. Sakhaee K, Maalouf NM, Kumar R, Pasch A, Moe OW 2011 Nephrolithiasis- associated bone disease: pathogenesis and treatment options. Kidney Int 79:393-403
33. Miller NL, Lingeman JE 2007 Management of kidney stones. BMJ 334:468-472 (Pubitemid 46586605)
34. Vieweg J, Teh C, Freed K, Leder RA, Smith RH, Nelson RH, Preminger GM 1998 Unenhanced helical computerized tomography for the evaluation of patients with acute flank pain. J Urol 160:679-684 (Pubitemid 29479486)
35. Hamm M, Knopfle E, Wartenberg S, Wawroschek F, Weckermann D, Harzmann R 2002 Low dose unenhanced helical computerized tomography for the evaluation of acute flank pain. J Urol 167:1687-1691 (Pubitemid 34240703)
36. Smith RC, Rosenfield AT, Choe KA, Essenmacher KR, Verga M, Glickman MG, Lange RC 1995 Acute flank pain: comparison of non-contrast-enhanced CT and intravenous urography. Radiology 194:789-794
37. Berger AD, Wu W, Eisner BH, Cooperberg MR, Duh QY, Stoller ML 2009 Patients with primary hyperparathyroidism - why do some form stones? J Urol 181:2141-2145
38. Rao DS, Phillips ER, Divine GW, Talpos GB 2004 Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415-5422 (Pubitemid 39518419)
39. Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M 2002 Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ 325:807-810 (Pubitemid 35177973)
40. Mollerup CL, Lindewald H 1999 Renal stones and primary hyperparathyroidism: natural history of renal stone disease after successful parathyroidectomy. World J Surg 23:173-176 (Pubitemid 29047375)
41. Posen S, Clifton-Bligh P, Reeve TS, Wagstaffe C, Wilkinson M 1985 Is parathyroidectomy of benefit in primary hyperparathyroidism? Q J Med 54:241-251 (Pubitemid 15136888)
42. Deaconson TF, Wilson SD, Lemann Jr J 1987 The effect of parathyroidectomy on the recurrence of nephrolithiasis. Surgery 102: 910-913 (Pubitemid 18010734)
43. Fraser WD 2009 Hyperparathyroidism. Lancet 374:145-158
44. Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C 2007 Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92:3114-3121 (Pubitemid 47236379)
45. Bollerslev J, Jansson S, Mollerup CL, Nordenström J, Lundgren E, Tørring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T 2007 Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687-1692 (Pubitemid 46997172)
46. Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM 1988 Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 67:1294-1298 (Pubitemid 19012967)
47. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP 1999 A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341:1249-1255 (Pubitemid 29489739)
48. Yu N, Donnan PT, Leese GP 15 December 2010 A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2010.03958.x
49. Bolland MJ, Grey AB, Orr-Walker BJ, Horne AM, Evans MC, Clearwater JM, Gamble GD, Reid IR 2008 Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism. N Z Med J 121:18-29
50. Udelsman R, Pasieka JL, Sturgeon C, Young JE, Clark OH 2009 Surgery for asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J Clin Endocrinol Metab 94:366-372
51. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A 1996 Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155: 839-843 (Pubitemid 26052660)
52. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A 2002 Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346: 77-84 (Pubitemid 34438897)
53. Sakhaee K, Poindexter JR, Griffith CS, Pak CY 2004 Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol 172:958-961 (Pubitemid 39096433)
54. Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT, Hollenbeck BK 2006 Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 368:1171-1179 (Pubitemid 44441578)
55. Keeley Jr FX, Assimos DG 2009 Clinical trials of the surgical management of urolithiasis: current status and future needs. Adv Chronic Kidney Dis 16:65-69
56. Worcester EM, Coe FL 2010 Calcium kidney stones. N Engl J Med 363:954-963
57. Pak CY 2008 Pharmacotherapy of kidney stones. Expert Opin Pharmacother 9:1509-1518 (Pubitemid 352005912)
58. Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I 2008 Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res 36:303-307
59. Bolland MJ, Grey AB, Gamble GD, Reid IR 2005 Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 90:1525-1530 (Pubitemid 40464014)
60. Amstrup AK, Rejnmark L, Vestergaard P, Sikjaer T, Rolighed L, Heickendorff L, Mosekilde L 2011 Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional study. Clin Endocrinol (Oxf) 74:130-136
61. Powell CR, Stoller ML, Schwartz BF, Kane C, Gentle DL, Bruce JE, Leslie SW 2000 Impact of body weight on urinary electrolytes in urinary stone formers. Urology 55:825-830 (Pubitemid 30330779)
62. Taylor EN, Curhan GC 2006 Body size and 24-hour urine composition. Am J Kidney Dis 48:905-915 (Pubitemid 44895373)
63. Eisner BH, Eisenberg ML, Stoller ML 2010 Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis. Urology 75:1289-1293
64. Wasserstein AG, Stolley PD, Soper KA, Goldfarb S, Maislin G, Agus Z 1987 Case-control study of risk factors for idiopathic calcium nephrolithiasis. Miner Electrolyte Metab 13:85-95 (Pubitemid 17081329)
65. Locker FG, Silverberg SJ, Bilezikian JP 1997 Optimal dietary calcium intake in primary hyperparathyroidism. Am J Med 102:543-550 (Pubitemid 27305117)
66. Chan AK, Duh QY, Katz MH, Siperstein AE, Clark OH 1995 Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg 222:402-412; discussion 412-414
67. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton 3rd LJ 1997 The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 126:433-440 (Pubitemid 27114471)
68. Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ 2008 The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93:3462-3470
69. Wu B, Haigh PI, Hwang R, Ituarte PH, Liu IL, Hahn TJ, Yeh MW 2010 Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism. J Clin Endocrinol Metab 95:4324-4330